Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Banco Santander Chile
BSAC
$16.1B
| $32M | 0.03% |
1,954,000
+132,400
| +7% | +$2.18M |
|
577
Fortuna Silver Mines
FSM
$3.1B
| $32M | 0.03% |
6,285,931
-1,104,200
| -15% | -$3.99M |
|
|
NVRO
578
DELISTED
NEVRO CORP.
NVRO
| $31.9M | 0.03% |
267,400
-126,217
| -32% | -$15M |
|
579
Mid-America Apartment Communities
MAA
$15.6B
| $31.9M | 0.03% |
278,449
-46,225
| -14% | -$5.21M |
|
580
Berkshire Hathaway Class B
BRK.B
$1.09T
| $31.7M | 0.03% |
177,665
+109,977
| +162% | +$20.1M |
|
581
Avantor
AVTR
$9.37B
| $31.7M | 0.03% |
+1,865,200
| New | +$30.4M |
|
582
Steris
STE
$23B
| $31.6M | 0.03% |
205,700
+161,410
| +364% | +$24.6M |
|
583
Axalta
AXTA
$7.93B
| $31.5M | 0.03% |
1,398,277
-1,433,100
| -51% | -$29.3M |
|
584
Anika Therapeutics
ANIK
$283M
| $31.5M | 0.03% |
834,917
+87,088
| +12% | +$2.87M |
|
|
ALX
585
Alexander's
ALX
$1.4B
| $31.5M | 0.03% |
130,614
+400
| +0.3% | +$107K |
|
586
Intuit
INTU
$98B
| $31.4M | 0.03% |
+105,960
| New | +$29.1M |
|
587
Teladoc Health
TDOC
$1.26B
| $31.3M | 0.03% |
164,200
+115,320
| +236% | +$20.2M |
|
588
Exponent
EXPO
$3.24B
| $31.3M | 0.03% |
386,900
-135,900
| -26% | -$9.78M |
|
589
International Flavors & Fragrances
IFF
$21.4B
| $31.2M | 0.03% |
+255,000
| New | +$32.2M |
|
590
Warrior Met Coal
HCC
$4.98B
| $31.2M | 0.03% |
2,028,479
-437,200
| -18% | -$5.96M |
|
591
Liberty Broadband Class C
LBRDK
$5.29B
| $31.2M | 0.03% |
251,700
-5,300
| -2% | -$665K |
|
592
Johnson Outdoors
JOUT
$512M
| $31M | 0.03% |
340,600
-12,700
| -4% | -$908K |
|
|
ATRI
593
DELISTED
Atrion Corp
ATRI
| $31M | 0.03% |
48,600
-100
| -0.2% | -$65.4K |
|
594
First Majestic Silver
AG
$9.26B
| $30.8M | 0.03% |
3,098,600
-1,755,438
| -36% | -$14.9M |
|
595
Forrester Research
FORR
$224M
| $30.7M | 0.03% |
959,424
-30,582
| -3% | -$971K |
|
|
SPTN
596
DELISTED
SpartanNash
SPTN
| $30.7M | 0.03% |
1,445,478
+729,366
| +102% | +$13.1M |
|
597
Roper Technologies
ROP
$39.3B
| $30.7M | 0.03% |
+79,100
| New | +$28.3M |
|
598
Stepan Co
SCL
$1.48B
| $30.7M | 0.03% |
316,100
-54,800
| -15% | -$5.15M |
|
|
CTT
599
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $30.7M | 0.03% |
3,464,067
-89,100
| -3% | -$690K |
|
600
Autohome
ATHM
$2.6B
| $30.7M | 0.03% |
406,018
+346,418
| +581% | +$27.1M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.